These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1546547)

  • 1. Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial.
    Sundblad C; Modigh K; Andersch B; Eriksson E
    Acta Psychiatr Scand; 1992 Jan; 85(1):39-47. PubMed ID: 1546547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.
    Sundblad C; Hedberg MA; Eriksson E
    Neuropsychopharmacology; 1993 Sep; 9(2):133-45. PubMed ID: 8216696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
    Steiner M; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D; Streiner D
    N Engl J Med; 1995 Jun; 332(23):1529-34. PubMed ID: 7739706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
    Yonkers KA; Halbreich U; Freeman E; Brown C; Endicott J; Frank E; Parry B; Pearlstein T; Severino S; Stout A; Stone A; Harrison W
    JAMA; 1997 Sep; 278(12):983-8. PubMed ID: 9307345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo.
    Landén M; Eriksson O; Sundblad C; Andersch B; Naessén T; Eriksson E
    Psychopharmacology (Berl); 2001 May; 155(3):292-8. PubMed ID: 11432692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?
    Wikander I; Sundblad C; Andersch B; Dagnell I; Zylberstein D; Bengtsson F; Eriksson E
    J Clin Psychopharmacol; 1998 Oct; 18(5):390-8. PubMed ID: 9790157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria.
    Steinberg S; Annable L; Young SN; Liyanage N
    Biol Psychiatry; 1999 Feb; 45(3):313-20. PubMed ID: 10023508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short onset of action of a serotonin reuptake inhibitor when used to reduce premenstrual irritability.
    Landén M; Erlandsson H; Bengtsson F; Andersch B; Eriksson E
    Neuropsychopharmacology; 2009 Feb; 34(3):585-92. PubMed ID: 18596686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoria.
    Steinberg S; Annable L; Young SN; Liyanage N
    Adv Exp Med Biol; 1999; 467():85-8. PubMed ID: 10721042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychiatric and psychological aspects of premenstrual syndrome].
    Limosin F; Ades J
    Encephale; 2001; 27(6):501-8. PubMed ID: 11865558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clomipramine on premenstrual syndrome.
    Eriksson E; Lisjö P; Sundblad C; Andersson K; Andersch B; Modigh K
    Acta Psychiatr Scand; 1990 Jan; 81(1):87-8. PubMed ID: 2330836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants in the treatment of premenstrual dysphoric disorder.
    Yonkers KA
    J Clin Psychiatry; 1997; 58 Suppl 14():4-10; discussion 11-3. PubMed ID: 9418742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women.
    Steiner M; Ravindran AV; LeMelledo JM; Carter D; Huang JO; Anonychuk AM; Simpson SD
    J Clin Psychiatry; 2008 Jun; 69(6):991-8. PubMed ID: 18517289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metergoline on symptoms in women with premenstrual dysphoric disorder.
    Roca CA; Schmidt PJ; Smith MJ; Danaceau MA; Murphy DL; Rubinow DR
    Am J Psychiatry; 2002 Nov; 159(11):1876-81. PubMed ID: 12411222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
    Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
    Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome.
    Eriksson E; Hedberg MA; Andersch B; Sundblad C
    Neuropsychopharmacology; 1995 Apr; 12(2):167-76. PubMed ID: 7779245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxetine as a treatment for premenstrual dysphoric disorder.
    Yonkers KA; Gullion C; Williams A; Novak K; Rush AJ
    J Clin Psychopharmacol; 1996 Feb; 16(1):3-8. PubMed ID: 8834412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
    Freeman EW; Kroll R; Rapkin A; Pearlstein T; Brown C; Parsey K; Zhang P; Patel H; Foegh M;
    J Womens Health Gend Based Med; 2001; 10(6):561-9. PubMed ID: 11559453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study.
    Gerhardsen G; Hansen AV; Killi M; Fornitz GG; Pedersen F; Roos SB
    Adv Ther; 2008 Jun; 25(6):595-607. PubMed ID: 18568441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward the content validity of premenstrual dysphoric disorder: do anger and irritability more than depressed mood represent treatment-seekers' experiences?
    Hartlage SA; Arduino KE
    Psychol Rep; 2002 Feb; 90(1):189-202. PubMed ID: 11898982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.